A prospective randomized controlled study on mouse nerve growth factor in the treatment of global developmental delay in children / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics
; (12): 786-790, 2021.
Article
em En
| WPRIM
| ID: wpr-888482
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVES@#To study the clinical effect of mouse nerve growth factor (mNGF) in the treatment of children with global developmental delay (GDD).@*METHODS@#A prospective clinical trial was conducted in 60 children with GDD who were treated in the First Affiliated Hospital of Anhui Medical University between July 2016 and July 2017. These children were randomly divided into two groups: conventional rehabilitation treatment and mNGF treatment group (@*RESULTS@#Before treatment and after 1.5 months of treatment, there was no significant difference in the developmental quotient (DQ) of each functional area of the Gesell Developmental Scale between the mNGF treatment and conventional rehabilitation treatment groups (@*CONCLUSIONS@#In children with GDD, routine rehabilitation training combined with mNGF therapy can significantly improve their cognitive, motor, and social abilities.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Estudos Prospectivos
/
Epilepsia
/
Habilidades Sociais
Tipo de estudo:
Observational_studies
Limite:
Animals
Idioma:
En
Revista:
Chinese Journal of Contemporary Pediatrics
Ano de publicação:
2021
Tipo de documento:
Article